APRT Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP2893a
Background:
A conserved feature of APRT is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis.
Other Names:
Adenine phosphoribosyltransferase, APRT, APRT
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2893a was selected from the N-term region of human APRT. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: APRT (HGNC:626)
Gene ID: 353
Primary Accession: P07741
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
A conserved feature of APRT is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis.
Other Names:
Adenine phosphoribosyltransferase, APRT, APRT
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2893a was selected from the N-term region of human APRT. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: APRT (HGNC:626)
Gene ID: 353
Primary Accession: P07741
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review